REQUEST A DEMO
Total
USD $0.00
Search more companies

Beres Pharma SRL (Romania)

Main Activities: Administrative Management and General Management Consulting Services
Full name: Beres Pharma SRL Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Beres Pharma SRL is a company based in Romania, with its head office in SANTANA DE MURES. The company operates in the Administrative Management and General Management Consulting Services industry. It was incorporated on March 10, 2010. Beres Pharma SRL currently employs 22 (2022) people. From the latest financial highlights, Beres Pharma SRL reported a net sales revenue drop of 7.68% in 2023. Its’ total assets recorded a negative growth of 11.26%. Beres Pharma SRL’s net profit margin increased by 2.81% in 2023.

Headquarters
Strada Voinicenilor Nr. 668
SANTANA DE MURES; Mures; Postal Code: 547565

Contact Details: Purchase the Beres Pharma SRL report to view the information.

Basic Information
Total Employees:
Purchase the Beres Pharma SRL report to view the information.
Outstanding Shares:
Purchase the Beres Pharma SRL report to view the information.
Registered Capital:
Purchase the Beres Pharma SRL report to view the information.
Incorporation Date:
March 10, 2010
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Beres Pharma SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
-7.68%
Total operating revenue
-10.02%
Operating profit (EBIT)
131.66%
EBITDA
66.78%
Net Profit (Loss) for the Period
258.81%
Total assets
-11.26%
Total equity
14.38%
Operating Profit Margin (ROS)
3.46%
Net Profit Margin
2.81%
Return on Equity (ROE)
8.56%
Quick Ratio
-0.14%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?